CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Top player positioning, 2017
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Surge in awareness about occupational health
3.4.1.2. Favorable regulatory environment
3.4.1.3. Rapid increase in aging workforce

3.4.2. Restraints

3.4.2.1. Emergence of small businesses and change in industry structure
3.4.2.2. Rise in incorporation of artificial intelligence (AI) and automation in the industry

3.4.3. Opportunity

3.4.3.1. Untapped potential of the emerging economies

CHAPTER 4: OCCUPATIONAL MEDICINES MARKET, BY APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Chemical poisoning

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Psychological disorder

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Non-induced hearing loss & vibration

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

4.5. Skin disorder

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

4.6. Chronic respiratory disease

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country

4.7. Pneumoconiosis

4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country

4.8. Musculoskeletal disorder

4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country

4.9. Cancer

4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country

4.10. Others

4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast, by region
4.10.3. Market analysis, by country

CHAPTER 5: OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY

5.1. Overview

5.1.1. Market size and forecast

5.2. Agriculture & forestry

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Construction

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Manufacturing

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Petroleum & mining

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

5.6. Transportation

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country

5.7. Other industries

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country

CHAPTER 6: OCCUPATIONAL MEDICINES MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America occupational medicines market size and forecast, by country

6.2.2.1. U.S. market size and forecast

6.2.2.1.1. U.S. occupational medicines market, by industry
6.2.2.1.2. U.S. occupational medicines market, by application

6.2.2.2. Canada market size and forecast

6.2.2.2.1. Canada occupational medicines market, by industry
6.2.2.2.2. Canada occupational medicines market, by application

6.2.2.3. Mexico market size and forecast

6.2.2.3.1. Mexico occupational medicines market, by industry
6.2.2.3.2. Mexico occupational medicines market, by application

6.2.3. North America occupational medicines market size and forecast, by application
6.2.4. North America occupational medicines market size and forecast, by industry

6.3. Europe

6.3.1. Key market trends, growth factors and opportunities
6.3.2. Europe occupational medicines market size and forecast, by country

6.3.2.1. Germany market size and forecast

6.3.2.1.1. Germany occupational medicines market, by industry
6.3.2.1.2. Germany occupational medicines market, by application

6.3.2.2. France market size and forecast

6.3.2.2.1. France occupational medicines market, by industry
6.3.2.2.2. France occupational medicines market, by application

6.3.2.3. UK market size and forecast

6.3.2.3.1. UK occupational medicines market, by industry
6.3.2.3.2. UK occupational medicines market, by application

6.3.2.4. Italy market size and forecast

6.3.2.4.1. Italy occupational medicines market, by industry
6.3.2.4.2. Italy occupational medicines market, by application

6.3.2.5. Spain market size and forecast

6.3.2.5.1. Spain occupational medicines market, by industry
6.3.2.5.2. Spain occupational medicines market, by application

6.3.2.6. Rest of Europe market size and forecast

6.3.2.6.1. Rest of Europe occupational medicines market, by industry
6.3.2.6.2. Rest of Europe occupational medicines market, by application

6.3.3. Europe occupational medicines market size and forecast, by application
6.3.4. Europe occupational medicines market size and forecast, by industry

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors and opportunities
6.4.2. Asia-Pacific occupational medicines market size and forecast, by country

6.4.2.1. Japan market size and forecast

6.4.2.1.1. Japan occupational medicines market, by industry
6.4.2.1.2. Japan occupational medicines market, by application

6.4.2.2. China market size and forecast

6.4.2.2.1. China occupational medicines market, by industry
6.4.2.2.2. China occupational medicines market, by application

6.4.2.3. India market size and forecast

6.4.2.3.1. India occupational medicines market, by industry
6.4.2.3.2. India occupational medicines market, by application

6.4.2.4. Australia market size and forecast

6.4.2.4.1. Australia occupational medicines market, by industry
6.4.2.4.2. Australia occupational medicines market, by application

6.4.2.5. South Korea market size and forecast

6.4.2.5.1. South Korea occupational medicines market, by industry
6.4.2.5.2. South Korea occupational medicines market, by application

6.4.2.6. Rest of Asia-Pacific market size and forecast

6.4.2.6.1. Rest of Asia-Pacific occupational medicines market, by industry
6.4.2.6.2. Rest of Asia-Pacific occupational medicines market, by application

6.4.3. Asia-Pacific occupational medicines market size and forecast, by application
6.4.4. Asia-Pacific occupational medicines market size and forecast, by industry

6.5. LAMEA

6.5.1. Key market trends
6.5.2. LAMEA occupational medicines market size and forecast, by country

6.5.2.1. Brazil market size and forecast

6.5.2.1.1. Brazil occupational medicines market, by industry
6.5.2.1.2. Brazil occupational medicines market, by application

6.5.2.2. Saudi Arabia market size and forecast

6.5.2.2.1. Saudi Arabia occupational medicines market, by industry
6.5.2.2.2. Saudi Arabia occupational medicines market, by application

6.5.2.3. South Africa market size and forecast

6.5.2.3.1. South Africa occupational medicines market, by industry
6.5.2.3.2. South Africa occupational medicines market, by application

6.5.2.4. Rest of LAMEA market size and forecast

6.5.2.4.1. Rest of LAMEA occupational medicines market, by industry
6.5.2.4.2. Rest of LAMEA occupational medicines market, by application

6.5.3. LAMEA occupational medicines market size and forecast, by application
6.5.4. LAMEA occupational medicines market size and forecast, by industry

CHAPTER 7: COMPANY PROFILES

7.1. Amgen Inc.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. AstraZeneca PLC

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. Bristol-Myers Squibb Company

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. Eli Lilly and Company

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance

7.5. F. Hoffmann-La Roche Ltd.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance

7.6. Johnson & Johnson

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product Portfolio
7.6.5.
7.6.6. Business performance
7.6.7. Key strategic moves and developments

7.7. Nestl S.A. (Galderma S.A.)

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.7.5.
7.7.6. Business performance
7.7.7. Key strategic moves and developments

7.8. Novartis AG

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product Portfolio
7.8.5. Business performance

7.9. Pfizer Inc.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5.
7.9.6. Business performance

7.10. Sanofi

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.10.5.
7.10.6. Business performance